Abstract:Context: The corticotropin-releasing factor (CRF, or corticotropin-releasing hormone) and arginine vasopressin systems have been implicated in the pathophysiology of anxiety and depressive disorders and response to antidepressant treatment.Objective: To study the association of genetic variants in 10 genes that regulate the CRF and arginine vasopressin systems with treatment response to citalopram in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) sample (N=1768).Design: Pharmacogenetic association study derived from the STAR*D study, a multicenter, prospective, open, 12-week effectiveness trial.Setting: Out patient primary care and psychiatric clinics.Patients: Individuals with nonpsychotic major depressive disorder for whom DNA was available who were subsequently treated with citalopram hydrobromide for 4 to 12 weeks.Intervention: Flexible doses of citalopram.Main Outcome Measure: Association of genetic polymorphisms in genes encoding the CRF system with response and remission to citalopram treatment at exit visit.Results: One single-nucleotide polymorphism (SNP) (rs10473984) within the CRHBP locus showed a significant association with both remission (P=6.0 x 10(-6); corrected, P=.0026) and reduction in depressive symptoms (P=7.0 x 10(-7); corrected, P=.00031) in response to citalopram. The T allele of this SNP was associated with poorer treatment outcome in 2 of the 3 ethnic subsamples (African American and Hispanic), despite large differences in minor allele frequency. This association was more pronounced in patients with features of anxious depression (P=.008). The nonresponse allele was shown to be associated with overall higher plasma corticotropin levels and more pronounced dexamethasone suppression of corticotropin.Conclusions: These data indicate that a genetic variant within the CRHBP locus affects response to citalopram in African American and Hispanic patients, suggesting a role for this gene and for the CRF system in antidepressant treatment response.

Sequence Polymorphisms of MC1R Gene and Their Association with Depression and Antidepressant Response

Association of APC and REEP5 Gene Polymorphisms with Major Depression Disorder and Treatment Response to Antidepressants in a Han Chinese Population

Association of Corticotropin-Releasing Hormone Receptor1 Gene SNP and Haplotype with Major Depression

5-Htr1a And 5-Htr2a Genetic Polymorphisms And Ssri Antidepressant Response In Depressive Chinese Patients

Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.

Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways

Association Study of Multidrug Resistance 1 Gene Polymorphisms with Efficacy and Adverse Drug Reaction of Paroxetine in Major Depressive Patients

Genetic Variations in Microrna Processing Genes Are Associated with Susceptibility in Depression

Association Of Polymorphisms In Genes Regulating The Corticotropin-Releasing Factor System With Antidepressant Treatment Response

Association of tryptophan hydroxylase 2 gene polymorphisms with major depression disorder and antidepressant treatment response

Rare Functional Variants Associated with Antidepressant Remission in Mexican-Americans

The melanocortin receptor genes are linked to and associated with the risk of polycystic ovary syndrome in Italian families

Serotonin 2A Receptor Polymorphism Rs3803189 Mediated by Dynamics of Default Mode Network: a Potential Biomarker for Antidepressant Early Response.

Corticotropin releasing hormone receptor CRHR1 gene is associated with tianeptine antidepressant response in a large sample of outpatients from real-life settings

Serotonin Transporter Gene: A New Polymorphism May Affect Response to Antidepressant Treatments in Major Depressive Disorder

A Meta-Analysis of 5-Hydroxytryptamine Receptor 1B Polymorphisms With Risk of Major Depressive Disorder and Suicidal Behavior

Association of PDE11A Global Haplotype with Major Depression and Antidepressant Drug Response.

A Polymorphism in the Microrna-30E Precursor Associated with Major Depressive Disorder Risk and P300 Waveform.

Serotonin transporter gene and antidepressant efficacy of selective serotonin reuptake inhibitors in adolescent depression

Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1

Differentially expressed genes related to major depressive disorder and antidepressant response: genome-wide gene expression analysis